| European Case Law Identifier: | ECLI:EP:BA:2002:T095099.20021111 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 11 November 2002 | ||||||||
| Case number: | T 0950/99 | ||||||||
| Application number: | 87303944.0 | ||||||||
| IPC class: | C12N 15/12 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Variants of decay accelerating factor (DAF) prepared by recombinant DNA technology | ||||||||
| Applicant name: | GENENTECH, INC., et al. | ||||||||
| Opponent name: | Imutran Limited | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of appeal (yes) Admissibility of additional documents filed with the statement of grounds of appeal (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t990950eu1.html
Date retrieved: 17 May 2021